# BCG Vaccination to Prevent COVID-19

> **NCT04632537** · PHASE3 · WITHDRAWN · sponsor: **Henry M. Jackson Foundation for the Advancement of Military Medicine**

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Tice® BCG (for intravesical use) BCG LIVE strain of the BCG (Merck) vaccine
- **DRUG:** Preservative-free saline

## Key facts

- **NCT ID:** NCT04632537
- **Lead sponsor:** Henry M. Jackson Foundation for the Advancement of Military Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-12-07
- **Primary completion:** 2021-03-23
- **Final completion:** 2021-03-23
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to funding - project never enrolled
- **Last updated:** 2021-03-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04632537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04632537, "BCG Vaccination to Prevent COVID-19". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04632537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*